Video Games Offer the Potential of “Experiential Medicine”
After a decade of work, scientists at UCSF’s Neuroscape Center have developed a suite of video game interventions that improve key aspects of cognition in aging adults.
University of California San Francisco
Give to UCSF
Displaying 901 - 930 of 16343
-
-
Fewer Asian, Black, Hispanic Patients Eligible for Drugs That May Delay Alzheimer’s Progression
A new study shows that fewer Black, Hispanic and Asian patients would qualify for these treatments that may slow Alzheimer’s progression, since cognitive impairment in these groups is more likely to be caused by other forms of dementia that may be unrelated to amyloid plaques.
-
Non-Opioid Compounds Squelch Pain Without Sedation
A newly identified set of molecules alleviated pain in mice while avoiding the sedating affect that limits the use of opiates, according to a new study led by researchers at UC San Francisco.
-
UCSF Researchers Discover How Vascular Cells Develop in Prenatal Brain
UCSF has revealed how blood vessel cells develop in the prenatal human brain, paving the way to fully understand the role of these cells in healthy brain development and disease.
-
Cellular Whodunnit Nabs Top Prize at 2022 Postdoc Slam
UCSF postdoc Elise Marsan, PhD, took first place for her cell-scale crime story, “Who Killed the Neurons?” at UCSF’s 5th Annual Postdoc Slam competition.
-
A Drug Based on LSD Appears to Treat Depression in Mice Without the Psychedelic Trip
-
Why It’s Important to Know if You Have Dense Breasts
-
Cardiovascular Health Technology to Be Fast-Tracked through Innovative Fellowship Program
The new UCSF Rosenman Institute BUILD™ Heart Health program is designed as an 11-month cycle of fully funded fellowships aimed at training the next generation of health technology entrepreneurs.
-
LSD-Like Molecules Counter Depression Without the Trip
Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.
-
Longevity Calculator Could Aid Planning After Dementia Diagnosis
-
Distinguished Clinical Researcher to Lead UCSF Interventional Cardiology Program
UCSF Health’s Heart and Vascular Center is welcoming Sammy Elmariah, MD, MPH, FACC, FAHA, FSCAI, as chief of its division of Interventional Cardiology and medical director of the division’s cardiac catheterization lab. Elmariah is a recognized expert in structural heart disease interventions and catheter-based valve therapies.
-
Parnassus Research and Academic Building Design and Site Improvements Move Forward
UCSF’s plans to build a new state-of-the-art research and academic building and rejuvenate the Parnassus Heights campus continues to build momentum.
-
Life Expectancy Tool May Improve Quality of Life for Patients With Dementia
A mortality prediction model for older adults with dementia may help physicians determine which treatments to provide while facilitating decision-making for patients and their families.
-
Surgeons Often Take a Fifth of the Lungs to Remove a Small Tumor. There May Be a Better Way
-
UCSF Statement on Improving the Equitable Distribution of MPX Vaccines
We are writing to update you on what UCSF is doing to ensure the equitable distribution of MPX vaccines in the face of ongoing vaccine shortages.
-
Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia
UCSF researchers Adam Staffaroni, PhD, and Adam Boxer, MD, PhD developed models of clinical and biomarker dynamics to determine the temporal sequence of biomarker and clinical changes in f-FTD before disease progression begins.
-
2022 UCSF Medal
UC San Francisco has bestowed its highest honor, the UCSF Medal, to five extraordinary individuals.
-
Hackathon Prepares Young Researchers for the Collaborative Science of the Future
On a sunny Friday, teams of aspiring young scientists gathered in the Clinical Sciences building at Parnassus Heights to look for treasure in a trillion data points about cancer.
-
Why Overdose Deaths Skyrocketed After Opioid Prescriptions Dropped
-
For Black Patients, Nixing ‘Race Adjustment’ May Improve Kidney Transplant Odds
Using equations to calculate kidney function that do not include race adjustments would result in Black patients gaining time before their kidneys fail.
-
UCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA
UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States.
-
Two States Are Trying to Set Age Limits for Diet Pill Sales
-
When Should You Get Your 2022 Flu Shot?
-
Dozens of Gut Bacteria Associated with Multiple Sclerosis
Researchers have found significant differences between the gut bacteria profiles of multiple sclerosis (MS) patients and healthy individuals, showing new pathways for potential treatment.
-
UCSF Calls for Proposals to Promote a Culture of Wellbeing
To support the wellbeing of the UCSF community, the University is now offering grants for projects that promote various forms of wellness.
-
Drug Turns Cancer Gene Into ‘Eat Me’ Flag for Immune System
A new therapy pulls forward a mutated version of the KRAS protein to help the immune system recognize and destroy cancer cells.
-
UCSF Scientist Says Biden’s Cancer Moonshot Achievable
-
Omicron Boosters: Do I Need One, and if So, When?
-
Dutch Queen Visits UCSF on Tech Trade Mission
UCSF hosted Queen Máxima of the Netherlands on Tuesday, as part of a Dutch trade mission to California.
-
Americans May Need Yearly Shots to Protect Against COVID-19